Pharmac has just announced that it will now cover the once daily Concerta for ADHD.
You can read the news release here.
Concerta is a once daily, long acting medication for ADHD.
Prior to this, Pharmac was only funding the generic Rubifen for ADHD, and occasionally it would cover the name brand Ritalin, as described here.

The funding for Concerta will allow for the prescriptions of this long acting medication only if the other two approved medicines don’t work effectively.

This is a step forward, though ideally, all would have access to Concerta.

To our New Zealand friends (i.e. Kiwis), please share your thoughts and comments below.

Best,
Dr. Kenny

p.s. to read about the dosing of concerta, visit: Concerta Dosage.

Share This